Abstract:Purpose: Antibiotic-resistant bacterial pneumonia poses a significant therapeutic challenge. In China, Chinese herbal compound (CHC) is commonly used to treat bacterial pneumonia. We aimed to evaluate the efficacy and safety of CHC and identify core herb combinations for the treatment of multidrug-resistant or extensively drug-resistant bacterial pneumonia. Methods: Stata 16 and TSA 0.9.5.10 beta software were used for meta-analysis and trial sequential analysis (TSA), respectively. Exploring the sources of heterogeneity through meta-regression and subgroup analysis. Results: Thirty-eight studies involving 2890 patients were included in the analyses. Meta-analysis indicated that CHC combined with antibiotics improved the response rate (RR = 1.24; 95% CI: 1.19–1.28; p < 0.0001) and microbiological eradication (RR = 1.41; 95% CI: 1.27–1.57; p < 0.0001), lowered the white blood cell count (MD = −2.09; 95% CI: −2.65 to −1.53; p < 0.0001), procalcitonin levels (MD = −0.49; 95% CI: −0.59 to −0.40; p < 0.0001), C-reactive protein levels (MD = −11.80; 95% CI: −15.22 to −8.39; p < 0.0001), Clinical Pulmonary Infection Scores (CPIS) (MD = −1.97; 95% CI: −2.68 to −1.26; p < 0.0001), and Acute Physiology and Chronic Health Evaluation (APACHE)-II score (MD = −4.08; 95% CI: −5.16 to −3.00; p < 0.0001), shortened the length of hospitalization (MD = −4.79; 95% CI: −6.18 to −3.40; p < 0.0001), and reduced the number of adverse events. TSA indicated that the response rate and microbiological eradication results were robust. Moreover, Scutellaria baicalensis Georgi , Fritillaria thunbergii Miq , Lonicera japonica Thunb , and Glycyrrhiza uralensis Fisch were identified as core CHC prescription herbs. Conclusion: Compared with antibiotic treatment, CHC + antibiotic treatment was superior in improving response rate, microbiological eradication, inflammatory response, CPIS, and APACHE-II score and shortening the length of hospitalization. Association rule analysis identified four core herbs as promising candidates for treating antibiotic-resistant bacterial pneumonia. However, large-scale clinical studies are still required. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42023410587.

Investigation and Analysis of the Situation of Chinese Herbs Prescription in the Prevention and Treatment of Atypical Pneumoina

A Data Mining-Based Analysis of Core Herbs on Different Patterns (Zheng) of Non-Small Cell Lung Cancer

Analysis on the Application of Single Chinese Herb of Traditional Chinese Medical Compound Prescriptions in Treating AIDS

Chinese herbal compound for multidrug-resistant or extensively drug-resistant bacterial pneumonia: a meta-analysis and trial sequential analysis with association rule mining to identify core herb combinations

Screening study on significant Chinese herb for anti-idiopathic pulmonary fibrosis by combining clinical experience prescriptions and molecular dynamics simulation technologies

Analysis of Chinese Herbal Medicines Used in Our Hospital During the Period 2002～2005

Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine—A Literature Analysis

Screening for anti-inflammatory and bronchorelaxant activities of 12 commonly used Chinese herbal medicines

Effect of Chinese Herbs on Mycoplasma Pneumonia of Swine

Survey and Analysis of Chinese Traditional Medicine Prescriptions in 2006 in Our Hospital

Analysis of major chemical constituents in Luan-Pao-prescription using liquid chromatography coupled with electrospray ionization mass spectrometry

Analysis of Outpatient Chinese Traditional Patent Medicine Prescriptions During the Third Quarter of 2008 in Our Hospital

Study on Characteristic of Syndrome Differentiation and Therapeutic Methods of Traditional Chinese Medicine on Allergic Rhinitis

Analysis of Adverse Reaction of Common Chinese Herbs with Antirheumatic Activity

Clinical Application of Traditional Chinese Medicine in Pneumonia Complicated with Heart Failure Based on Data Mining Algorithms

Concentrations, Sources and Health Risk Assessment of Polycyclic Aromatic Hydrocarbons in Chinese Herbal Medicines

Prevention and treatment of viral respiratory infections by traditional Chinese herbs

Screening the Best Combination of Herbs for Anti-Helicobacter Pylori by Orthogonal Test Method

Analyzing Professor YANG Wenhua's Herbal Administration Experience for Leukemia Treatment Based on Traditional Chinese Medicine Inheritance Support System

Hot topics in Chinese herbal drugs research documented in PubMed/MEDLINE by authors inside China and outside of China in the past 10 years: based on co-word cluster analysis

[Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining]